Loading...
Globant SA is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators are bearish, options sentiment is neutral to slightly bearish, and the company's financial performance shows declining profitability. Analyst ratings and price target revisions also reflect cautious sentiment. While there is potential for a slight short-term uptick, the lack of strong positive catalysts and the absence of Intellectia Proprietary Trading Signals suggest holding off on a purchase for now.
The technical indicators are bearish. The MACD is below 0 and negatively contracting, RSI is neutral at 44.4, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 47.552, with resistance levels at 53.198 and 56.686, and support levels at 41.906 and 38.418.

The stock has a 70% chance of a slight short-term gain (0.34% in the next day, 2.24% in the next week).
Analysts have lowered price targets, citing sector-wide challenges and weak discretionary IT spending. Financial performance shows declining net income (-24.09% YoY) and EPS (-25.51% YoY). Gross margin also dropped (-3.76% YoY).
In Q3 2025, revenue grew marginally by 0.40% YoY to $617.14 million, but net income dropped significantly by -24.09% YoY to $33.1 million. EPS fell by -25.51% YoY to 0.73, and gross margin declined to 34.8%. These metrics indicate slowing growth and profitability.
Analysts are cautious. Guggenheim lowered the price target to $65 from $80, maintaining a Buy rating. JPMorgan reduced the target to $68 from $75 with a Neutral rating, citing weak IT spending and a challenging Q1. UBS raised the target to $75 but kept a Neutral rating, expressing concerns about pipeline visibility. Truist initiated coverage with a Hold rating and a $72 target, highlighting the need for evidence of growth re-acceleration.